Literature DB >> 6214578

Mechanism for the suppression of gamma-interferon responsiveness in mice after thermal injury.

F Suzuki, R B Pollard.   

Abstract

As reported previously, gamma-interferon production was decreased after the administration of inducers to thermally injured mice as compared with noninjured controls. Similarly, spleen cells from injured mice had decreased ability to produce interferon in vitro after stimulation with inducers. The present study demonstrated that the decrease in interferon production was associated with the presence of suppressor cells in the spleen of burned mice that were capable of inhibiting interferon production by normal splenic lymphocytes in vitro. Passive transfer of spleen cells containing suppressor cell activity derived from injured mice induced suppression in normal mice, and the time of the appearance of suppressor cell activity in injured mouse spleens closely approximated the time of the appearance of the suppression of interferon production observed in mice after thermal injury. The suppressor cells were characterized as a population of macrophages by the following: they adhered to plastic surface and could be removed from spleen cells by carbonyl-iron treatment; treatment of plastic-adherent cells with anti-Thy-1.2 and anti-mouse immunoglobulin antisera followed by complement failed to abrogate the suppression produced by these cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries.

Authors:  T Katakura; T Yoshida; M Kobayashi; D N Herndon; F Suzuki
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus.

Authors:  T Utsunomiya; M Kobayashi; R B Pollard; F Suzuki
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Rationale, design and performance of a clinical trial to investigate interferon-gamma (Imukin) in the prophylactic treatment of severe burns-related infections.

Authors:  J D Ioannovich; R D Hinzmann; G Deichsel; G G Steinmann
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

Review 4.  Trauma equals danger--damage control by the immune system.

Authors:  Veit M Stoecklein; Akinori Osuka; James A Lederer
Journal:  J Leukoc Biol       Date:  2012-05-31       Impact factor: 4.962

5.  Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice.

Authors:  Manabu Kinoshita; Shuhji Seki; Satoshi Ono; Nariyoshi Shinomiya; Hoshio Hiraide
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

6.  Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermal injury: role in the subsequent development of burn-associated type 2 T-cell responses.

Authors:  Katsunori Furukawa; Makiko Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

7.  Protective effect of shigyaku-to, a traditional Chinese herbal medicine, on the infection of herpes simplex virus type 1 (HSV-1) in mice.

Authors:  K Ikemoto; T Utsunomiya; M A Ball; M Kobayashi; R B Pollard; F Suzuki
Journal:  Experientia       Date:  1994-05-15

8.  2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells.

Authors:  K Ikemoto; M Kobayashi; T Fukumoto; M Morimatsu; R B Pollard; F Suzuki
Journal:  Experientia       Date:  1996-02-15

9.  Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice.

Authors:  K Takagi; F Suzuki; R E Barrow; S E Wolf; D N Herndon
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

10.  Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.

Authors:  F Suzuki; R R Brutkiewicz; R B Pollard
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.